Dental News - Canada invests in Septodont’s pharma division to combat COVID-19

Dental Tribune International

Tue. 6. April 2021

save

CAMBRIDGE, Ontario, Canada: Septodont, a global pharmaceutical and medical device company specializing in dental pain management, has announced that its Canada-based pharma division, Novocol Pharma, will receive funding of over C$32 million from the Canadian government. The investment is part of a countrywide initiative to advance vaccines and therapeutics for COVID-19 on a national level.

As stated in a press release, the government of Canada had made investments of approximately C$1 billion in industrial research, vaccine and pharmaceutical development, and biomanufacturing capacity by mid-March. In order to further strengthen the private sector in the fight against the global COVID-19 pandemic, it has now made new monies available via its Strategic Innovation Fund.

As announced by Septodont, the investment in Novocol will help support a C$72.6 million project to expand the company’s facilities in Ontario, and this will increase biomanufacturing capacity for fill-finish sterile injectables, including vaccines.

“By creating such capacity and capabilities, Novocol will contribute to strengthening Canada’s preparedness for future pandemics, as well as create skilled jobs and economic development in the country’s biopharmaceutical ecosystem. As a contract development and manufacturing organization, our investment will provide valuable services to support Canadian and foreign biopharmaceutical innovators, starting from clinical trial materials through to commercial scale manufacturing,” Septodont CEO Olivier Schiller commented.

According to Johns Hopkins University, Canada had reported almost one million cases of COVID-19 and about 23,000 related deaths by the beginning of April.

To post a reply please login or register

Canada invests in oral health access projects

NORTH BAY, Ontario, Canada: In 2022, the Canadian government introduced an ambitious new national dental plan; however, the incremental co-payment-based ...

IDEM in Singapore postponed owing to COVID-19 restrictions

SINGAPORE: The International Dental Exhibition and Meeting (IDEM) 2022 has been postponed owing to the travel and safety restrictions currently in place in ...

Dentists in Italy face unemployment owing to COVID-19

MILAN, Italy: Italy has become the European country worst affected by the COVID-19 outbreak, its confirmed cases of infection currently reaching 74,386, ...

Researchers in the UK and India aim to combat antibiotic overprescription in dentistry

LEEDS, England: While antibiotics remain essential for treating infectious diseases, their global efficacy is declining owing to the rise of antimicrobial ...

Artificial intelligence to combat soaring drug prices in US

WASHINGTON, U.S.: Drug prices in the U.S. are the highest in any developed country in the world, with a particular increase over the past decade. This trend...

Dentists in Germany no more likely to catch COVID-19 than general population—study

GREIFSWALD, Germany: A study by researchers at University Medicine Greifswald compared the risk of SARS-CoV-2 transmission among dental teams with that of ...

Scientists examine halitosis in COVID‐19 patients

BRNO, Czech Republic: A recent study carried out by scientists from Masaryk University in Brno has suggested that there may be a link between new‐onset ...

FDI offers COVID-19 guidance to dental professionals

GENEVA, Switzerland: The SARS-CoV-2 outbreak is causing significant disruption to dental practice worldwide. Oral health professionals, dental associations ...

UK government unveils plan to combat festering dental crisis

LONDON, England: The current state of public health dentistry in the UK is, without question, lamentable. Plagued by financial, personnel and regulatory ...

Interceptive aligner treatment in a growing Class II, Division 1 patient

Early intervention in growing patients with skeletal Class II malocclusion aims to reduce sagittal discrepancies, guide dentofacial development and minimise...

Education

Live webinar
Wed. 29 April 2026
7:00 pm EST (New York)